1. Home
  2. SONO vs IOVA Comparison

SONO vs IOVA Comparison

Compare SONO & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$14.73

Market Cap

1.8B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.97

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
IOVA
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
SONO
IOVA
Price
$14.73
$4.97
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$19.67
$9.00
AVG Volume (30 Days)
2.2M
16.5M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
0.52
N/A
Revenue
$1,443,276,000.00
N/A
Revenue This Year
$5.04
$47.74
Revenue Next Year
$6.53
$40.31
P/E Ratio
$27.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.12
$1.76
52 Week High
$19.82
$5.64

Technical Indicators

Market Signals
Indicator
SONO
IOVA
Relative Strength Index (RSI) 52.31 58.94
Support Level $12.77 $3.77
Resistance Level $15.35 $5.63
Average True Range (ATR) 0.70 0.40
MACD 0.08 0.07
Stochastic Oscillator 48.76 64.89

Price Performance

Historical Comparison
SONO
IOVA

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: